enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in enVVeno Medical Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2022
- Shares held
- 1.66M
- −125.2K (−7.0%) vs. Q3 2022
- Total value
- $8.46M
- −$2.75M (−24.5%) vs. Q3 2022
- New holders
- 3
- 6 more added
- Sold out
- 2
- 5 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 36 | $5.40M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $17.3M |
| Q1 2024 | 32 | $19.8M |
| Q4 2023 | 30 | $21.8M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $13.7M |
| Q3 2021 | 16 | $8.74M |
| Q2 2021 | 14 | $6.16M |
| Q1 2021 | 16 | $5.24M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $5 | 0.00% | −1,673−99.9% | Reduced |
| Bank of America Corp | 10 | $51 | 0.00% | +10 | New |
| Newbridge Financial Services Group, Inc. | 20 | $102 | 0.00% | 00.0% | Unchanged |
| EWG Elevate Inc. | 315 | $1.61K | 0.00% | +315 | New |
| Tower Research Capital LLC (TRC) | 1,858 | $9.00K | 0.00% | −790−29.8% | Reduced |
| Wells Fargo & Company | 2,059 | $10.5K | 0.00% | +2+0.1% | Added |
| Financial Perspectives, Inc | 3,278 | $16.7K | 0.01% | 00.0% | Unchanged |
| Sepio Capital, LP | 10,800 | $55.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 11,087 | $56.5K | 0.00% | −8,896−44.5% | Reduced |
| Advisor Group Holdings, Inc. | 11,415 | $58.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 13,300 | $67.8K | 0.00% | −4,200−24.0% | Reduced |
| Northern Trust Corp | 16,377 | $83.5K | 0.00% | +2,471+17.8% | Added |
| State Street Corp | 21,500 | $109.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 21,493 | $110.0K | 0.00% | +40.0% | Added |
| Arthur M. Cohen & Associates, LLC | 24,000 | $122.4K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 30,430 | $155.2K | 0.00% | −1,855−5.7% | Reduced |
| BlackRock Inc. | 33,810 | $172.4K | 0.00% | +146+0.4% | Added |
| Susquehanna International Group, LLP | 37,960 | $193.6K | 0.00% | +37,960 | New |
| Geode Capital Management, LLC | 83,083 | $423.0K | 0.00% | +908+1.1% | Added |
| Kingdon Capital Management, L.L.C. | 219,180 | $1.12M | 0.29% | 00.0% | Unchanged |
| Vanguard Group Inc | 335,797 | $1.71M | 0.00% | +1660.0% | Added |
| Perceptive Advisors LLC | 781,615 | $3.99M | 0.11% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −149,720−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |